C-MER Medical buys back 148,000 shares, first move under 2026 mandate

Bulletin Express07-08

C-MER Medical Holdings Limited disclosed that it repurchased 148,000 ordinary shares on-market on 8 July 2026 at prices ranging between HKD 0.99 and HKD 1.00, for a total consideration of HKD 0.15 million.

The transaction represents 0.0122 % of the company’s 1.21 billion issued shares (excluding treasury shares) outstanding prior to the buyback. All repurchased shares have been retained as treasury shares, lifting the treasury share balance to 21.28 million and trimming the free-float share count to 1.21 billion.

The buyback is the first utilisation of the mandate approved by shareholders on 20 May 2026, which authorises C-MER Medical to repurchase up to 123.23 million shares. To date, 0.012 % of that limit has been used. In accordance with Hong Kong Stock Exchange rules, the company is subject to a moratorium on issuing new shares or selling treasury shares until 7 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1113584456?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-08 17:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113584456","market":"us","top_or_hot":-1,"title":"C-MER Medical buys back 148,000 shares, first move under 2026 mandate","media":"Bulletin Express","content":"<p>C-MER Medical Holdings Limited disclosed that it repurchased 148,000 ordinary shares on-market on 8 July 2026 at prices ranging between HKD 0.99 and HKD 1.00, for a total consideration of HKD 0.15 million.</p>\n<p>The transaction represents 0.0122 % of the company’s 1.21 billion issued shares (excluding treasury shares) outstanding prior to the buyback. All repurchased shares have been retained as treasury shares, lifting the treasury share balance to 21.28 million and trimming the free-float share count to 1.21 billion.</p>\n<p>The buyback is the first utilisation of the mandate approved by shareholders on 20 May 2026, which authorises C-MER Medical to repurchase up to 123.23 million shares. To date, 0.012 % of that limit has been used. In accordance with Hong Kong Stock Exchange rules, the company is subject to a moratorium on issuing new shares or selling treasury shares until 7 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C-MER Medical buys back 148,000 shares, first move under 2026 mandate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC-MER Medical buys back 148,000 shares, first move under 2026 mandate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-08 17:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>C-MER Medical Holdings Limited disclosed that it repurchased 148,000 ordinary shares on-market on 8 July 2026 at prices ranging between HKD 0.99 and HKD 1.00, for a total consideration of HKD 0.15 million.</p>\n<p>The transaction represents 0.0122 % of the company’s 1.21 billion issued shares (excluding treasury shares) outstanding prior to the buyback. All repurchased shares have been retained as treasury shares, lifting the treasury share balance to 21.28 million and trimming the free-float share count to 1.21 billion.</p>\n<p>The buyback is the first utilisation of the mandate approved by shareholders on 20 May 2026, which authorises C-MER Medical to repurchase up to 123.23 million shares. To date, 0.012 % of that limit has been used. In accordance with Hong Kong Stock Exchange rules, the company is subject to a moratorium on issuing new shares or selling treasury shares until 7 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03309","symbol_name":"希玛医疗","start_time":0,"source_url":"","article_id":"1113584456","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113584456","pubTimestamp":1783501350,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"C-MER Medical Holdings Limited disclosed that it repurchased 148,000 ordinary shares on-market on 8 July 2026 at prices ranging between HKD 0.99 and HKD 1.00, for a total consideration of HKD 0.15...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03309":"希玛医疗"},"translate_title":"C-MER Medical回购148,000股股票，这是2026年授权下的第一步","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03309":1},"content_text":"C-MER Medical Holdings Limited disclosed that it repurchased 148,000 ordinary shares on-market on 8 July 2026 at prices ranging between HKD 0.99 and HKD 1.00, for a total consideration of HKD 0.15 million.\nThe transaction represents 0.0122 % of the company’s 1.21 billion issued shares (excluding treasury shares) outstanding prior to the buyback. All repurchased shares have been retained as treasury shares, lifting the treasury share balance to 21.28 million and trimming the free-float share count to 1.21 billion.\nThe buyback is the first utilisation of the mandate approved by shareholders on 20 May 2026, which authorises C-MER Medical to repurchase up to 123.23 million shares. To date, 0.012 % of that limit has been used. In accordance with Hong Kong Stock Exchange rules, the company is subject to a moratorium on issuing new shares or selling treasury shares until 7 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113584456","isCrawlerRequest":true}